Romanov Dmitry V, Brazhnikov Aleksey Iu, Andreyuk Denis S, Zakharova Natalia V, Bravve Lidia V, Kovaleva Vasilisa A, Abbazova Evgeniya V, Goncharov Dmitriy B, Titova Irina V, Domonova Elvira A, Kostyuk George P
I.M. Sechenov First Moscow State Medical University (Sechenov University).
Mental Health Research Centre.
Consort Psychiatr. 2020 Sep 2;1(1):22-29. doi: 10.17650/2712-7672-2020-1-1-22-29.
The association between schizophrenia and toxoplasmosis has been demonstrated in a number of studies: the prevalence of schizophrenia is significantly higher in toxoplasmosis positive subjects than in those with negative status. However, the clinical significance of this association remains poorly understood.
To identify clinical phenomena that are typical for toxoplasmosis-associated ( seropositive) schizophrenia compared to Toxoplasma-seronegative schizophrenia.
A retrospective database analysis of serum samples from 105 inpatients with schizophrenia (ICD-10code: F20; including 55 male patients; mean age of 27.4 6.4 years) was carried out. The clinical examination involved a structured interview including ICD-10 and E. Bleulers criteria for schizophrenia and psychometric tests(Positive and Negative Scales of PANSS). Serum antibodies (IgG) to were identified using ELISA. The statistical significance of any differences were evaluated using the non-parametric Mann-Whitney (U) and X tests.
The proportion of seropositive patients in the sample was 16.2%. Comparing schizophrenia patients, who were seropositive or seronegative for toxoplasmosis, there were no statistically significant differences for the mean total PANSS score, mean PANSS-P, PANSS-N or PANSS-G scores. For the majority of PANSS items, differences were also statistically insignificant, except for G5 and G6mannerism and posturing. Seropositive patients had a higher score for this item than seronegative patients: 3.5 versus 2.1 points (U=389.5; р=0.001). Depression, on the contrary,was less pronounced in seropositive than seronegative patients: 1.4 versus 2.4 points (U=509.5; р=0.023). In addition,in seropositive patients, the frequency of symptoms such as mutism according to ICD-10 criteria for schizophrenia was significantly higher (23.5% versus 3.4%, X=9.27, р=0.013), and the whole group of catatonic symptoms according to the E. Bleulers criteria for schizophrenia was higher (52.9% versus 28.4%, X=3.916, p = 0.048).
The association between a positive toxoplasmosis status in patients with schizophrenia and catatonic symptoms has been revealed for the first time and should be verified in larger studies.
多项研究证实了精神分裂症与弓形虫病之间的关联:弓形虫病检测呈阳性的受试者中精神分裂症的患病率显著高于检测呈阴性的受试者。然而,这种关联的临床意义仍知之甚少。
确定与弓形虫血清阴性的精神分裂症相比,弓形虫病相关(血清阳性)精神分裂症的典型临床现象。
对105例精神分裂症住院患者(国际疾病分类第十版代码:F20;包括55例男性患者;平均年龄27.4±6.4岁)的血清样本进行回顾性数据库分析。临床检查包括结构化访谈,其中包括国际疾病分类第十版和E. 布鲁勒的精神分裂症标准以及心理测量测试(阳性和阴性症状评定量表)。使用酶联免疫吸附测定法鉴定针对弓形虫的血清抗体(IgG)。使用非参数曼-惠特尼(U)检验和卡方检验评估任何差异的统计学意义。
样本中血清阳性患者的比例为16.2%。比较弓形虫病血清阳性或血清阴性的精神分裂症患者,阳性和阴性症状评定量表总分均值、阳性症状量表均值、阴性症状量表均值或一般精神病理量表均值均无统计学显著差异。对于大多数阳性和阴性症状评定量表项目,差异也无统计学意义,但G5和G6(怪癖和姿势)项目除外。血清阳性患者该项目的得分高于血清阴性患者:3.5分对2.1分(U=389.5;p=0.001)。相反,血清阳性患者的抑郁症状不如血清阴性患者明显:1.4分对2.4分(U=509.5;p=0.023)。此外,在血清阳性患者中,根据国际疾病分类第十版精神分裂症标准,缄默等症状的发生率显著更高(23.5%对3.4%,χ²=9.27,p=0.013),并且根据E. 布鲁勒精神分裂症标准,整个紧张症症状组的发生率更高(52.9%对28.4%,χ²=3.916,p = 0.048)。
首次揭示了精神分裂症患者弓形虫病阳性状态与紧张症症状之间的关联,应在更大规模的研究中加以验证。